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Using evidence to improve quality of
pharmacy-delivered medical abortion
FROM EVIDENCE TO IMPACT: A look at how STEP UP
research was used to impact policies and programmes
The goal of family planning and reproductive health operations research is to generate
evidence that helps policies and programmes maximize access to and quality of services
for women and their families. Yet the crucial step of ensuring the utilization of that
evidence often receives inconsistent or inadequate attention. There is relatively little
monitoring and reporting on whether and to what effect research findings are utilized, or
on the nature, process, and efficacy of the strategies employed to achieve this.
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The goal of this case study is to document an activity of the STEP UP research
programme consortium which resulted in successful evidence utilization. This is to both
demonstrate the positive impact STEP UP is having on family planning and reproductive
health policies, as well as to document the process by which this was achieved so as to
inform future research projects on successful strategies and lessons learned.

SUMMARY
As a partner in the STEP UP research
programme consortium, Marie Stopes
International has conducted high-quality
research and enabled significant impact on
health policies and programming. STEP UP
research on quality of care for medical abortion
(MA) has provided the evidence base for
strengthening of MSI’s provision of safe
abortion, specifically MA, across the globe,
enabling such impact as:
 Development of MSI’s safe abortion and
post-abortion care strategy and best
practice guidance for implementation

Funded by

 Development and implementation of
mechanisms to ensure women obtaining
MA from pharmacies have access to
information (including telephone advice line
services and improved product packaging
information)



Implementation of ongoing
pharmacy education and provision
of informational materials to
expand awareness of MA

INTRODUCTION
The availability of misoprostol and mifepristone in
pharmacies and drug shops has increased women’s
access to safe, non-surgical methods of abortion in many
countries, resulting in declines in mortality and morbidity
from unsafe abortion.1 Yet women’s access to accurate
information about these medications remains limited,
especially when the drug sellers themselves lack
adequate information and training. Without access to
accurate information as well as high quality products,
incorrect use of medical abortion drugs may limit their
effectiveness.
Marie Stopes International (MSI), a research partner in
STEP UP, has been uniquely positioned to produce,
implement and scale up STEP UP evidence, resulting in
research uptake at both a regional and global level by
informing MSI programming, internal guidance, and
strategy.

THE PROJECTS
Two primary STEP UP activities informed MSI’s safe
abortion and post-abortion care strategy and ongoing
programme improvements:


A systematic review examining published studies
assessing the level and quality of pharmacy and drug
shop provision of medical abortion in low- and middleincome countries, as well as interventions to improve
quality of provision.2
 A study assessing the availability, use, and quality of
care for MA provision in private pharmacies in
Kenya. 3

Without access to accurate
information as well as high quality
products, incorrect use of medical
abortion drugs may limit their
effectiveness.

KEY STUDY RESULTS
In Kenya,
 Pharmacy workers are providing women with MA
drugs and information: 62% of pharmacy workers
provided information on abortion methods to mystery
shoppers, and 28% offered MA drugs.
 Demand for abortion services is high: pharmacies that
provide MA information and drugs reported an
average of 12 women seeking abortion services per
month. Among pharmacies that do not provide MA
information and drugs, most (74%) said that their
clients ask for these services.
 However, pharmacy workers do not know correct MA
regimens, side effects, or the legal status of MA. Only
9% of pharmacy workers could state the correct WHO
approved mifepristone-misoprostol MA regimen.
Knowledge of the misoprostol-only regimen was
higher (19%).
 Among those who did know the correct regimen,
many were unable to name side effects or potential
complications.
 Pharmacy workers need and want more training on
MA methods, recognition and management of
complications, referrals, and abortion law.
Globally:
 Despite widespread awareness and provision of MA
drugs, most studies found that pharmacy workers and
drug sellers had poor knowledge of effective regimens
 Evidence on interventions to improve pharmacy
provision of MA indicated that training, call centre
support, and medical detailing could be effective in
improving drug seller knowledge, but evidence was
limited and generally of poor quality.
 Programmatic attention should focus on the
development and rigorous evaluation of innovative
interventions to improve women’s access to
information about MA self-management in low- and
middle-income countries.

MAKING AN IMPACT
Marie Stopes International has over 600 fixed clinics, 3,600
social franchises, 520 outreach teams, and 550 community
midwives in 37 countries. To inform MSI clinical guidelines
and practices is to contribute to improving the care of
millions of women. STEP UP evidence on pharmacy
provision of MA has been utilized by MSI in several ways:

A call centre toolkit for MSI programmes has been
developed, and programmes are supported to
strengthen their call centres through continuing
investment in technical expertise and resources. The
impact of call centres on women’s access to accurate
information about MA is now being evaluated in
Zambia.

Supporting high quality MA information provision by
pharmacy workers in Kenya

KEY LESSONS LEARNED

Training sessions on MA were conducted with pharmacy
staff, doctors, nurses and clinical officers by Marie Stopes
Kenya (MSK), including MSK staff and non-MSK staff.
STEP UP research data informed the training content and
improved educational materials, as the research had
identified the greatest knowledge gaps for these providers.
To improve access to information for MA users, MSK also
actively promoted their call centre phone number to
pharmacies and their clients by printing the call centre
phone number on promotional materials and packaging.
The survey had shown that many pharmacists provided
MA drugs without any packaging, information, or support,
so this intervention aimed to ensure that women would
have access to the required information and support after
leaving the pharmacy.
Building a global strategy for safe abortion and postabortion care
The research has also influenced MSI’s global safe
abortion and post-abortion care strategy, which was
developed in 2016-17. As a result of this evidence on
pharmacy provision of MA, the strategy highlights the
importance of improving access to information about MA
for women who may be using these products (within the
local legal framework), as well as improving access to
information among health professionals such as
pharmacists. The strategy offers programmes guidance
and advice on how to achieve this through evidence-based
case studies, such as that of Marie Stopes Kenya.

The vertically integrated structure of MSI allowed for
efficient and widespread uptake of STEP UP evidence.
Research is able to inform not only operations
(enhancing service delivery) but also strategy
development (ensuring relevance, innovation, and
sustained benefits of services to communities).

A feedback system of operations
research and operational guidance
Several aspects of MSI internal structure enabled
successful research uptake of STEP UP evidence.
Informing best practice
MSI uses ‘Success Models’ to capture all best practice
guidance for operations, including evidenced examples
of how guidance has been successfully implemented in
particular country programmes. The ‘Success Models’
are documents which identify key rules or
recommendations for successful implementation of
each of MSI’s service delivery channels (fixed clinics,
mobile outreach teams, social franchise, community
midwives, public sector support), and for specific
technical areas such as safe abortion and postabortion care, and reaching adolescents.
Each rule or recommendation includes guidance on its
rationale, how to implement, and evidenced examples
of where it has been successfully implemented.
Through this continuing feedback loop, new evidence
informs best practice guidance and programmatic
decision-making.

Strengthening MSI call centres as key drivers for
improving sexual and reproductive health awareness

Investing in evidence

The STEP UP systematic review revealed the need for
improved knowledge and awareness of MA, and the
important role that hotlines and call centres can play in
ensuring women have access to information. MSI’s safe
abortion and post-abortion care strategy recognises the
key role of the call centre for providing information and
referrals.

The feedback loop of ‘Success Models’ also helps to
identify where more evidence is needed in order to
improve operations, expand access, or strengthen
quality. For example, if there is a lack of evidence for a
specific intervention, or it is unclear how to address an
operational challenge, this will be prioritised as an area
where more research is needed.

Investment in evidence at MSI is based on twelve
strategic research priorities4 that were defined in 2016
during a cross-MSI research scoping and prioritisation
effort. Alongside the Success Models, the MSI research
strategy aligns the organisation in terms of priorities for
investment in evidence generation. To ensure
sustainable impact, to the maximum extent possible,
strategic and operational research questions are
answered using routine data as MSI has a wide range
of high quality data sources such as its electronic
health information system.
Communicating results
To ensure maximum use of new evidence, research is
integrated into Success Model guidance, and it is
widely disseminated through global and country
leadership. This ensures that there is shared
understanding across the organisation of “what works”.
Evidence is shared through targeted evidence briefs,
with clear implications for operations highlighted, and
wherever possible, wider bodies of evidence are
collated to show research findings in context.

CONCLUSION
Pharmacy workers are key in expanding access to safe
methods of abortion worldwide and reducing harm from
unsafe abortion. Pharmacy staff require improved
support to ensure women receive accurate information,
and mechanisms are needed to expand women’s direct
access to information about medical abortion. To this
end, STEP UP research on pharmacy provision of MA
has been successfully utilized at wide scale throughout
the MSI network. The embedded partnership of
research activities and service delivery was the crucial
link that offered an effective conduit for research
utilization.
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